Symbols / UNH $286.88 +0.49%
UNH Chart
About
UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease and drug therapy management. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; Medicaid plans, including Temporary Assistance to Needy Families; Children's Health Insurance Programs; Dual SNPs; Long-Term Services and Supports; Aged, Blind and Disabled; and other federal, state, and community health care programs. and health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. UnitedHealth Group Incorporated was founded in 1974 and is based in Eden Prairie, Minnesota.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Healthcare Plans | Market Cap | 260.39B |
| Enterprise Value | 321.60B | Income | 12.06B | Sales | 447.57B |
| Book/sh | 103.87 | Cash/sh | 30.98 | Dividend Yield | 3.10% |
| Payout | 65.99% | Employees | 390000 | IPO | — |
| P/E | 21.70 | Forward P/E | 14.41 | PEG | — |
| P/S | 0.58 | P/B | 2.76 | P/C | — |
| EV/EBITDA | 14.87 | EV/Sales | 0.72 | Quick Ratio | 0.70 |
| Current Ratio | 0.79 | Debt/Eq | 81.62 | LT Debt/Eq | — |
| EPS (ttm) | 13.22 | EPS next Y | 19.91 | EPS Growth | -99.90% |
| Revenue Growth | 12.30% | Earnings | 2026-04-16 | ROA | 3.90% |
| ROE | 12.54% | ROIC | — | Gross Margin | 18.53% |
| Oper. Margin | 0.34% | Profit Margin | 2.69% | Shs Outstand | 907.68M |
| Shs Float | 900.01M | Short Float | 1.63% | Short Ratio | 1.18 |
| Short Interest | — | 52W High | 606.36 | 52W Low | 234.60 |
| Beta | 0.38 | Avg Volume | 9.07M | Volume | 4.27M |
| Target Price | $362.54 | Recom | Buy | Prev Close | $285.49 |
| Price | $286.88 | Change | 0.49% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$362.54
Mean price target
2. Current target
$286.88
Latest analyst target
3. DCF / Fair value
$274.92
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$286.88
Low
$255.00
High
$440.00
Mean
$362.54
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-05 | main | Mizuho | Outperform → Outperform | $350 |
| 2026-02-02 | main | Truist Securities | Buy → Buy | $370 |
| 2026-02-02 | main | JP Morgan | Overweight → Overweight | $389 |
| 2026-01-30 | main | Barclays | Overweight → Overweight | $327 |
| 2026-01-30 | main | Wells Fargo | Overweight → Overweight | $370 |
| 2026-01-28 | main | Jefferies | Buy → Buy | $340 |
| 2026-01-28 | main | Leerink Partners | Outperform → Outperform | $345 |
| 2026-01-28 | main | RBC Capital | Outperform → Outperform | $361 |
| 2026-01-28 | main | Oppenheimer | Outperform → Outperform | $385 |
| 2026-01-28 | main | UBS | Buy → Buy | $410 |
| 2026-01-23 | main | Morgan Stanley | Overweight → Overweight | $409 |
| 2026-01-05 | main | Barclays | Overweight → Overweight | $391 |
| 2025-10-30 | main | TD Cowen | Hold → Hold | $338 |
| 2025-10-30 | main | Bernstein | Outperform → Outperform | $440 |
| 2025-10-29 | main | UBS | Buy → Buy | $430 |
| 2025-10-29 | main | RBC Capital | Outperform → Outperform | $408 |
| 2025-10-29 | main | Piper Sandler | Overweight → Overweight | $417 |
| 2025-10-17 | main | Jefferies | Buy → Buy | $409 |
| 2025-10-14 | init | Goldman Sachs | — → Buy | $406 |
| 2025-10-09 | main | JP Morgan | Overweight → Overweight | $425 |
News
RSS: Latest UNH news- Mariner LLC Boosts Stock Holdings in UnitedHealth Group Incorporated $UNH - MarketBeat ue, 17 Mar 2026 12
- UNH Expands Doulas: Better Outcomes or Margin Play Ahead? - The Globe and Mail ue, 17 Mar 2026 16
- UnitedHealth: Stabilizing, But Not Yet A Buy - Seeking Alpha ue, 17 Mar 2026 01
- UnitedHealth Stock: Here’s the 110% Upside Case - TIKR.com Sun, 15 Mar 2026 07
- Doulas at work: UnitedHealthcare plans pregnancy support for up to 7.2M people - Stock Titan Mon, 16 Mar 2026 11
- Is UnitedHealth Group (UNH) Pricing Reflect Sector Pressures After A 39% Share Price Decline - Yahoo Finance hu, 12 Mar 2026 18
- UnitedHealth Group Stock (UNH) Opinions on Medicare Advantage Rate Proposals - Quiver Quantitative ue, 24 Feb 2026 08
- UnitedHealth Group Incorporated stock rises 1.2% amid dividend payout and analyst scrutiny - AD HOC NEWS ue, 17 Mar 2026 06
- UnitedHealth Group (UNH) Stock Surges Amid Market Decline - Eudaimonia and Co hu, 12 Mar 2026 10
- Mairs & Power Inc. Purchases 12,787 Shares of UnitedHealth Group Incorporated $UNH - MarketBeat ue, 17 Mar 2026 12
- UnitedHealth Group: Still A Generational Buying Opportunity (NYSE:UNH) - Seeking Alpha Mon, 16 Mar 2026 23
- UnitedHealth Group Incorporated $UNH Shares Sold by Focus Partners Wealth - MarketBeat ue, 17 Mar 2026 08
- UnitedHealth: Why AI Is The Secret Weapon For The Turnaround (NYSE:UNH) - Seeking Alpha Mon, 16 Mar 2026 22
- Marshfield Associates Grows Position in UnitedHealth Group Incorporated $UNH - MarketBeat ue, 17 Mar 2026 11
- Maxi Investments CY Ltd Acquires 13,560 Shares of UnitedHealth Group Incorporated $UNH - MarketBeat ue, 17 Mar 2026 12
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 8855 | — | — | Stock Award(Grant) at price 0.00 per share. | NOEL TIMOTHY JOHN | Officer | — | 2026-02-23 00:00:00 | D |
| 1 | 8855 | — | — | Stock Award(Grant) at price 0.00 per share. | CONWAY PATRICK HUGH M.D. | Officer | — | 2026-02-23 00:00:00 | D |
| 2 | 7084 | — | — | Stock Award(Grant) at price 0.00 per share. | ZAETTA CHRISTOPHER R | Officer | — | 2026-02-23 00:00:00 | D |
| 3 | 4871 | — | — | Stock Award(Grant) at price 0.00 per share. | MCSWEENEY ERIN L | Officer | — | 2026-02-23 00:00:00 | D |
| 4 | 2436 | — | — | Stock Award(Grant) at price 0.00 per share. | ROOS THOMAS E | Officer | — | 2026-02-23 00:00:00 | D |
| 5 | 8855 | 2500121 | — | Stock Award(Grant) at price 282.34 per share. | DEVEYDT WAYNE S | Chief Financial Officer | — | 2026-02-23 00:00:00 | D |
| 6 | 168 | — | — | Stock Award(Grant) at price 0.00 per share. | HOOPER MICHELE J. | Director | — | 2026-01-02 00:00:00 | D |
| 7 | 125 | — | — | Stock Award(Grant) at price 0.00 per share. | GOTTLIEB SCOTT | Director | — | 2026-01-02 00:00:00 | D |
| 8 | 279 | — | — | Stock Award(Grant) at price 0.00 per share. | BAKER CHARLES D | Director | — | 2026-01-02 00:00:00 | D |
| 9 | 280 | — | — | Stock Award(Grant) at price 0.00 per share. | GARCIA PAUL REU | Director | — | 2026-01-02 00:00:00 | D |
Financials
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -34.19M | -2.00B | 0.00 | 0.00 |
| TaxRateForCalcs | 0.13 | 0.24 | 0.20 | 0.22 |
| NormalizedEBITDA | 23.32B | 36.39B | 36.33B | 31.84B |
| TotalUnusualItems | -265.00M | -8.31B | 0.00 | 0.00 |
| TotalUnusualItemsExcludingGoodwill | -265.00M | -8.31B | 0.00 | 0.00 |
| NetIncomeFromContinuingOperationNetMinorityInterest | 12.06B | 14.40B | 22.38B | 20.12B |
| ReconciledDepreciation | 4.36B | 4.10B | 3.97B | 3.40B |
| ReconciledCostOfRevenue | 364.65B | 310.88B | 280.66B | 244.54B |
| EBITDA | 23.06B | 28.08B | 36.33B | 31.84B |
| EBIT | 18.70B | 23.98B | 32.36B | 28.43B |
| NetInterestIncome | -4.00B | -3.91B | -3.25B | -2.09B |
| InterestExpense | 4.00B | 3.91B | 3.25B | 2.09B |
| NormalizedIncome | 12.29B | 20.71B | 22.38B | 20.12B |
| NetIncomeFromContinuingAndDiscontinuedOperation | 12.06B | 14.40B | 22.38B | 20.12B |
| TotalExpenses | 428.60B | 367.99B | 339.26B | 295.73B |
| TotalOperatingIncomeAsReported | 18.96B | 32.29B | 32.36B | 28.43B |
| DilutedAverageShares | 911.00M | 929.00M | 938.00M | 950.00M |
| BasicAverageShares | 905.84M | 915.00M | 924.00M | 934.00M |
| DilutedEPS | 13.23 | 15.51 | 23.86 | 21.18 |
| BasicEPS | 13.31 | 15.74 | 24.22 | 21.54 |
| DilutedNIAvailtoComStockholders | 12.06B | 14.40B | 22.38B | 20.12B |
| NetIncomeCommonStockholders | 12.06B | 14.40B | 22.38B | 20.12B |
| NetIncome | 12.06B | 14.40B | 22.38B | 20.12B |
| MinorityInterests | -751.00M | -837.00M | -763.00M | -519.00M |
| NetIncomeIncludingNoncontrollingInterests | 12.81B | 15.24B | 23.14B | 20.64B |
| NetIncomeContinuousOperations | 12.81B | 15.24B | 23.14B | 20.64B |
| TaxProvision | 1.89B | 4.83B | 5.97B | 5.70B |
| PretaxIncome | 14.70B | 20.07B | 29.11B | 26.34B |
| OtherIncomeExpense | -265.00M | -8.31B | 4.09B | 2.03B |
| SpecialIncomeCharges | -265.00M | -8.31B | 0.00 | 0.00 |
| GainOnSaleOfBusiness | -265.00M | -8.31B | 0.00 | 0.00 |
| GainOnSaleOfSecurity | 4.09B | 2.03B | 2.32B | |
| NetNonOperatingInterestIncomeExpense | -4.00B | -3.91B | -3.25B | -2.09B |
| InterestExpenseNonOperating | 4.00B | 3.91B | 3.25B | 2.09B |
| OperatingIncome | 18.96B | 32.29B | 32.36B | 28.43B |
| OperatingExpense | 63.95B | 57.11B | 58.60B | 51.18B |
| OtherOperatingExpenses | 59.59B | 53.01B | 54.63B | 47.78B |
| DepreciationAmortizationDepletionIncomeStatement | 4.36B | 4.10B | 3.97B | 3.40B |
| DepreciationAndAmortizationInIncomeStatement | 4.36B | 4.10B | 3.97B | 3.40B |
| GrossProfit | 82.92B | 89.40B | 90.96B | 79.62B |
| CostOfRevenue | 364.65B | 310.88B | 280.66B | 244.54B |
| TotalRevenue | 447.57B | 400.28B | 371.62B | 324.16B |
| OperatingRevenue | 447.57B | 400.28B | 371.62B | 324.16B |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 905.84M | 915.00M | 924.00M | 934.00M |
| ShareIssued | 905.84M | 915.00M | 924.00M | 934.00M |
| NetDebt | 54.02B | 51.59B | 37.11B | 34.26B |
| TotalDebt | 78.39B | 76.90B | 62.54B | 57.62B |
| TangibleBookValue | -36.86B | -37.34B | -30.17B | -29.98B |
| InvestedCapital | 172.50B | 169.56B | 151.29B | 135.40B |
| WorkingCapital | -24.32B | -17.99B | -20.62B | -20.17B |
| NetTangibleAssets | -36.86B | -37.34B | -30.17B | -29.98B |
| CommonStockEquity | 94.11B | 92.66B | 88.76B | 77.77B |
| TotalCapitalization | 166.43B | 165.02B | 147.02B | 132.28B |
| TotalEquityGrossMinorityInterest | 101.70B | 102.59B | 98.92B | 86.35B |
| MinorityInterest | 7.59B | 9.93B | 10.16B | 8.57B |
| StockholdersEquity | 94.11B | 92.66B | 88.76B | 77.77B |
| GainsLossesNotAffectingRetainedEarnings | -2.06B | -3.39B | -7.03B | -8.39B |
| OtherEquityAdjustments | -2.06B | -3.39B | -7.03B | -8.39B |
| RetainedEarnings | 95.60B | 96.04B | 95.77B | 86.16B |
| AdditionalPaidInCapital | 559.00M | 0.00 | 0.00 | |
| CapitalStock | 9.00M | 9.00M | 9.00M | 9.00M |
| CommonStock | 9.00M | 9.00M | 9.00M | 9.00M |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 207.88B | 195.69B | 174.80B | 159.36B |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 92.99B | 91.92B | 75.75B | 70.12B |
| OtherNonCurrentLiabilities | 18.25B | 15.94B | 14.46B | 12.84B |
| NonCurrentDeferredLiabilities | 2.42B | 3.62B | 3.02B | 2.77B |
| NonCurrentDeferredTaxesLiabilities | 2.42B | 3.62B | 3.02B | 2.77B |
| LongTermDebtAndCapitalLeaseObligation | 72.32B | 72.36B | 58.26B | 54.51B |
| LongTermDebt | 72.32B | 72.36B | 58.26B | 54.51B |
| CurrentLiabilities | 114.90B | 103.77B | 99.05B | 89.24B |
| OtherCurrentLiabilities | 28.05B | 27.35B | 27.07B | 26.28B |
| CurrentDeferredLiabilities | 3.41B | 3.32B | 3.35B | 3.08B |
| CurrentDeferredRevenue | 3.41B | 3.32B | 3.35B | 3.08B |
| CurrentDebtAndCapitalLeaseObligation | 6.07B | 4.54B | 4.27B | 3.11B |
| CurrentDebt | 6.07B | 4.54B | 4.27B | 3.11B |
| PayablesAndAccruedExpenses | 77.37B | 68.56B | 64.35B | 56.77B |
| Payables | 77.37B | 68.56B | 64.35B | 56.77B |
| AccountsPayable | 77.37B | 68.56B | 64.35B | 56.77B |
| TotalAssets | 309.58B | 298.28B | 273.72B | 245.71B |
| TotalNonCurrentAssets | 219.00B | 212.50B | 195.28B | 176.64B |
| OtherNonCurrentAssets | 23.01B | 19.59B | 17.30B | 15.03B |
| InvestmentsAndAdvances | 54.25B | 52.35B | 47.61B | 43.73B |
| GoodwillAndOtherIntangibleAssets | 130.97B | 130.00B | 118.93B | 107.75B |
| OtherIntangibleAssets | 20.47B | 23.27B | 15.19B | 14.40B |
| Goodwill | 110.50B | 106.73B | 103.73B | 93.35B |
| NetPPE | 10.76B | 10.55B | 11.45B | 10.13B |
| AccumulatedDepreciation | -7.55B | -6.97B | -7.04B | -6.93B |
| GrossPPE | 18.31B | 17.52B | 18.49B | 17.06B |
| MachineryFurnitureEquipment | 13.83B | 12.95B | 12.20B | 10.84B |
| BuildingsAndImprovements | 4.09B | 4.21B | 5.57B | 5.52B |
| LandAndImprovements | 387.00M | 364.00M | 712.00M | 697.00M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 90.58B | 85.78B | 78.44B | 69.07B |
| OtherCurrentAssets | 9.75B | 8.21B | 9.84B | 10.71B |
| PrepaidAssets | 5.32B | |||
| Receivables | 52.72B | 48.45B | 38.97B | 30.45B |
| OtherReceivables | 29.70B | 26.09B | 17.69B | 12.77B |
| AccountsReceivable | 23.02B | 22.36B | 21.28B | 17.68B |
| AllowanceForDoubtfulAccountsReceivable | -1.21B | -985.00M | -1.00B | -877.00M |
| GrossAccountsReceivable | 24.23B | 23.35B | 22.28B | 18.56B |
| CashCashEquivalentsAndShortTermInvestments | 28.12B | 29.11B | 29.63B | 27.91B |
| OtherShortTermInvestments | 3.76B | 3.80B | 4.20B | 4.55B |
| CashAndCashEquivalents | 24.36B | 25.31B | 25.43B | 23.36B |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| FreeCashFlow | 16.07B | 20.70B | 25.68B | 23.40B |
| RepurchaseOfCapitalStock | -5.54B | -9.00B | -8.00B | -7.00B |
| RepaymentOfDebt | -3.05B | -3.00B | -2.12B | -3.02B |
| IssuanceOfDebt | 2.97B | 17.81B | 6.39B | 14.82B |
| IssuanceOfCapitalStock | 827.00M | 1.85B | 1.35B | 1.25B |
| CapitalExpenditure | -3.62B | -3.50B | -3.39B | -2.80B |
| InterestPaidSupplementalData | 4.03B | 3.59B | 3.04B | 1.95B |
| IncomeTaxPaidSupplementalData | 3.71B | 4.62B | 6.08B | 5.22B |
| EndCashPosition | 24.36B | 25.31B | 25.43B | 23.36B |
| OtherCashAdjustmentOutsideChangeinCash | -355.00M | -219.00M | 0.00 | 0.00 |
| BeginningCashPosition | 25.31B | 25.43B | 23.36B | 21.38B |
| EffectOfExchangeRateChanges | 40.00M | -61.00M | 97.00M | 34.00M |
| ChangesInCash | -632.00M | 165.00M | 1.97B | 1.96B |
| FinancingCashFlow | -11.64B | -3.51B | -11.53B | 4.23B |
| CashFlowFromContinuingFinancingActivities | -11.64B | -3.51B | -11.53B | 4.23B |
| NetOtherFinancingCharges | 264.00M | -3.48B | -2.40B | 3.43B |
| CashDividendsPaid | -7.92B | -7.53B | -6.76B | -5.99B |
| CommonStockDividendPaid | -7.92B | -7.53B | -6.76B | -5.99B |
| NetCommonStockIssuance | -4.72B | -7.15B | -6.65B | -5.75B |
| CommonStockPayments | -5.54B | -9.00B | -8.00B | -7.00B |
| CommonStockIssuance | 827.00M | 1.85B | 1.35B | 1.25B |
| NetIssuancePaymentsOfDebt | 726.00M | 14.66B | 4.28B | 12.54B |
| NetShortTermDebtIssuance | 807.00M | -151.00M | 11.00M | 732.00M |
| NetLongTermDebtIssuance | -81.00M | 14.81B | 4.27B | 11.80B |
| LongTermDebtPayments | -3.05B | -3.00B | -2.12B | -3.02B |
| LongTermDebtIssuance | 2.97B | 17.81B | 6.39B | 14.82B |
| InvestingCashFlow | -8.69B | -20.53B | -15.57B | -28.48B |
| CashFlowFromContinuingInvestingActivities | -8.69B | -20.53B | -15.57B | -28.48B |
| NetOtherInvestingChanges | -915.00M | -4.14B | -275.00M | 2.62B |
| NetInvestmentPurchaseAndSale | 361.00M | 525.00M | -1.78B | -6.84B |
| SaleOfInvestment | 17.73B | 27.83B | 16.54B | 11.99B |
| PurchaseOfInvestment | -17.37B | -27.31B | -18.31B | -18.82B |
| NetBusinessPurchaseAndSale | -4.51B | -13.41B | -10.14B | -21.46B |
| PurchaseOfBusiness | -4.51B | -13.41B | -10.14B | -21.46B |
| NetPPEPurchaseAndSale | -3.62B | -3.50B | -3.39B | -2.80B |
| PurchaseOfPPE | -3.62B | -3.50B | -3.39B | -2.80B |
| OperatingCashFlow | 19.70B | 24.20B | 29.07B | 26.21B |
| CashFlowFromContinuingOperatingActivities | 19.70B | 24.20B | 29.07B | 26.21B |
| ChangeInWorkingCapital | 2.28B | -808.00M | 1.64B | 2.25B |
| ChangeInOtherWorkingCapital | 163.00M | -197.00M | 203.00M | 126.00M |
| ChangeInOtherCurrentLiabilities | -1.37B | -1.03B | ||
| ChangeInOtherCurrentAssets | -4.61B | -4.14B | -2.44B | -1.37B |
| ChangeInPayablesAndAccruedExpense | 7.49B | 4.97B | 7.00B | 6.02B |
| ChangeInPayable | 7.49B | 4.97B | 7.00B | 6.02B |
| ChangeInAccountPayable | 1.67B | 2.46B | 3.52B | 1.96B |
| ChangeInReceivables | -764.00M | -1.44B | -3.11B | -2.52B |
| ChangesInAccountReceivables | -764.00M | -1.44B | -3.11B | -2.52B |
| OtherNonCashItems | 763.00M | -3.36B | -505.00M | -331.00M |
| StockBasedCompensation | 971.00M | 1.02B | 1.06B | 925.00M |
| DeferredTax | -1.75B | -296.00M | -245.00M | -673.00M |
| DeferredIncomeTax | -1.75B | -296.00M | -245.00M | -673.00M |
| DepreciationAmortizationDepletion | 4.36B | 4.10B | 3.97B | 3.40B |
| DepreciationAndAmortization | 4.36B | 4.10B | 3.97B | 3.40B |
| OperatingGainsLosses | 265.00M | 8.31B | ||
| GainLossOnSaleOfBusiness | 265.00M | 8.31B | 0.00 | 0.00 |
| NetIncomeFromContinuingOperations | 12.81B | 15.24B | 23.14B | 20.64B |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for UNH
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|